NCT04263571View on ClinicalTrials.gov

Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels

UnknownOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

AnemiaIV Iron

Trial Locations (2)

48149

RECRUITING

Dept. of Anesthesiology, Intensive Care and Pain Medicine, UKM, Münster

60590

NOT_YET_RECRUITING

University Hospital Frankfurt, Frankfurt am Main

Sponsors

Lead Sponsor

Goethe University

Collaborators (1)

Pharmacosmos A/S

All Listed Sponsors

collaborator

Pharmacosmos A/S

INDUSTRY

collaborator

University Hospital Muenster

OTHER

lead

Goethe University

OTHER